MEASURIN Drug Patent Profile
✉ Email this page to a colleague
When do Measurin patents expire, and when can generic versions of Measurin launch?
Measurin is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in MEASURIN is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEASURIN?
- What are the global sales for MEASURIN?
- What is Average Wholesale Price for MEASURIN?
Summary for MEASURIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,998 |
| DailyMed Link: | MEASURIN at DailyMed |
Recent Clinical Trials for MEASURIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AIM ImmunoTech Inc. | Phase 2 |
| Roswell Park Cancer Institute | Phase 2 |
| University of California, San Francisco | Phase 2 |
US Patents and Regulatory Information for MEASURIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | MEASURIN | aspirin | TABLET, EXTENDED RELEASE;ORAL | 016030-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
